Portfolio company
Vortex
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company produces automated liquid biopsy systems that isolate circulating tumour cells from blood samples for researchers and clinicians in the oncology sector.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Vortex Biotech
This company provides circulating tumour cell isolation systems for clinicians, researchers and pharmaceutical companies to support cancer diagnosis and patient monitoring.
Avant Genomics
The company develops an automated platform for liquid biopsy sample preparation to assist clinical laboratories in cancer detection and monitoring.
Smartcatch
This company develops microtechnology devices for isolating circulating tumour cells from blood samples to assist researchers and clinicians in cancer diagnosis and monitoring.
LiquidCell Dx
This company develops blood-based liquid biopsy tests for tumor microenvironment profiling to help pharmaceutical companies and clinical partners predict cancer therapy responses.
Epiliquid
This company develops blood-based liquid biopsy tests for early cancer detection and monitoring, serving clinical laboratories and medical practitioners.
Infiniplex
This company develops liquid biopsy solutions using blood tests to monitor genetic biomarkers for cancer screening and precision oncology decisions for healthcare providers.
Fyr Bio
This company develops liquid biopsy diagnostic tools and biomarkers using extracellular vesicle enrichment technology for healthcare providers and pharmaceutical researchers.
Hermes Biosciences
This company develops automated benchtop systems for isolating extracellular vesicles from biological samples for clinical researchers, pharmaceutical companies and academic institutions.
